Therapeutic Asset Ratings

200 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Epirubicin Metastatic Malignant Neoplasm to Brain	Massachusetts General Hospital	P2	CCC (53)
Epirubicin Progressive Brain Metastases	Massachusetts General Hospital	P2	CCC (53)
Epirubicin Recurrent Brain Metastases	Massachusetts General Hospital	P2	CCC (53)
Hyaluronidase fihj Transplant Ineligible	Massachusetts General Hospital	P2	CCC (53)
IMMUNOGLOBULIN G, ANTI-(HUMAN CALCITONIN GENE-RELATED PEPTIDE RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER Chronic Pain Syndrome	Massachusetts General Hospital	P2	CCC (53)
IMMUNOGLOBULIN G, ANTI-(HUMAN CALCITONIN GENE-RELATED PEPTIDE RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER Schwannoma	Massachusetts General Hospital	P2	CCC (53)
IMMUNOGLOBULIN G, ANTI-(HUMAN CALCITONIN GENE-RELATED PEPTIDE RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER Schwannomatosis	Massachusetts General Hospital	P2	CCC (53)
Infliximab Major Depressive Disorder	Massachusetts General Hospital	P2	CCC (53)
Infliximab Chemical Colitis	Massachusetts General Hospital	P2	CCC (53)
Infliximab Inflammatory Disease	Massachusetts General Hospital	P2	CCC (53)
Infliximab Skin Cancer	Massachusetts General Hospital	P2	CCC (53)
Ipilimumab Metastatic Cancer Colorectal	Massachusetts General Hospital	P2	CCC (53)
Ivonescimab Disease Of Genetic Or Genomic Mechanism	Massachusetts General Hospital	P2	CCC (53)
Losartan Breast Cancer	Massachusetts General Hospital	P2	CCC (53)
Losartan Ovarian Cancer	Massachusetts General Hospital	P2	CCC (53)
Neratinib Estrogen-Receptor Positive Breast Cancer	Massachusetts General Hospital	P2	CCC (53)
Neratinib Invasive Breast Carcinoma	Massachusetts General Hospital	P2	CCC (53)
Neratinib Progesterone-Receptor Positive Breast Cancer	Massachusetts General Hospital	P2	CCC (53)
Oxytocin Obesity, Adolescent	Massachusetts General Hospital	P2	CCC (53)
Palbociclib Metastatic Malignant Neoplasm to Brain	Massachusetts General Hospital	P2	CCC (53)
Palbociclib Progressive Brain Metastases	Massachusetts General Hospital	P2	CCC (53)
Palbociclib Recurrent Brain Metastases	Massachusetts General Hospital	P2	CCC (53)
PARTHENOLIDE (CONSTITUENT OF FEVERFEW) Mild Cognitive Impairment (MCI)	Massachusetts General Hospital	P2	CCC (53)
PARTHENOLIDE (CONSTITUENT OF FEVERFEW) Subjective Cognitive Decline (SCD)	Massachusetts General Hospital	P2	CCC (53)
Pembrolizumab Metastatic Malignant Neoplasm to Brain	Massachusetts General Hospital	P2	CCC (53)

Showing 76 to 100 of 200 assets

PreviousPage 4 of 8Next